BTA 0.00% 57.0¢ biota holdings limited

research data sankyo tjw, page-3

  1. TJW
    716 Posts.
    DMA

    Sankyo/Biota probably thought the time is ripe because of Tamiflu problem in Japan and the zero sale of Relenza for the seasonal flu market by GSK.

    Hope the claim is 500 million US dollars rather than AUSSIE dollars.

    Cheers
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.